ETOPOSIDE

ETOPOSIDE was reported 73448 times

ETOPOSIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 GROWING TERATOMA SYNDROME 32 0.9697
1 LYMPHOID TISSUE HYPOPLASIA 148 0.9673
2 THYMUS HYPOPLASIA 152 0.8736
3 HUMAN BOCAVIRUS INFECTION 133 0.7037
4 HAEMATOPOIETIC STEM CELL MOBILISATION 31 0.4844
5 OVARIAN GERM CELL TERATOMA 37 0.4625
6 CHORIOCARCINOMA 32 0.4051
7 BASAL GANGLION DEGENERATION 35 0.3723
8 MEDULLOBLASTOMA RECURRENT 40 0.3540
9 RENAL SALT-WASTING SYNDROME 136 0.3469
10 NEPHROBLASTOMA 42 0.3307
11 CYSTITIS BACTERIAL 110 0.3254
12 MALIGNANT TRANSFORMATION 137 0.3051
13 NOROVIRUS TEST POSITIVE 97 0.2985
14 NEUROBLASTOMA RECURRENT 58 0.2857
15 TERATOMA 57 0.2651
16 DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY 251 0.2650
17 MYCOBACTERIUM CHELONAE INFECTION 184 0.2490
18 DISSEMINATED ASPERGILLOSIS 114 0.2415
19 HIGH-GRADE B-CELL LYMPHOMA 45 0.2406
20 MEDULLOBLASTOMA 35 0.2349
21 REFRACTORY CANCER 48 0.2254
22 MENINGITIS TUBERCULOUS 125 0.2236
23 TREATMENT RELATED SECONDARY MALIGNANCY 45 0.2217
24 OVARIAN FAILURE 117 0.2187
25 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 482 0.2184
26 PRIMARY HYPOGONADISM 34 0.2166
27 SECONDARY IMMUNODEFICIENCY 261 0.2148
28 BLOOD STEM CELL TRANSPLANT FAILURE 45 0.2093
29 ABSCESS BACTERIAL 73 0.2011
30 OSTEOSARCOMA 74 0.1922
31 NEUROBLASTOMA 73 0.1906
32 SWEAT GLAND TUMOUR 44 0.1872
33 T-CELL TYPE ACUTE LEUKAEMIA 38 0.1863
34 CAECITIS 78 0.1733
35 B-CELL LYMPHOMA RECURRENT 94 0.1731
36 HEPATOSPLENIC T-CELL LYMPHOMA 64 0.1725
37 CORONA VIRUS INFECTION 71 0.1651
38 CENTRAL NERVOUS SYSTEM FUNGAL INFECTION 38 0.1638
39 ENGRAFTMENT SYNDROME 90 0.1523
40 CONGENITAL APLASIA 45 0.1447
41 NEUTROPENIC INFECTION 136 0.1421
42 PSEUDOMONAL SEPSIS 245 0.1398
43 CENTRAL HYPOTHYROIDISM 46 0.1390
44 MANTLE CELL LYMPHOMA RECURRENT 59 0.1356
45 HUMAN HERPESVIRUS 6 INFECTION 244 0.1290
46 VENOOCCLUSIVE LIVER DISEASE 636 0.1287
47 NEUTROPENIC COLITIS 263 0.1271
48 TISSUE INFILTRATION 37 0.1254
49 ACUTE MYELOMONOCYTIC LEUKAEMIA 31 0.1225
50 REFRACTORY ANAEMIA WITH AN EXCESS OF BLASTS 37 0.1182
51 PARAINFLUENZAE VIRUS INFECTION 180 0.1182
52 FEBRILE NEUTROPENIA 7745 0.1166
53 VENOOCCLUSIVE DISEASE 286 0.1141
54 APLASIA 222 0.1133
55 ENTEROBACTER INFECTION 190 0.1130
56 CYTOMEGALOVIRUS CHORIORETINITIS 220 0.1127
57 CHLOROMA 47 0.1114
58 ASPERGILLUS INFECTION 725 0.1104
59 DIFFUSE LARGE B-CELL LYMPHOMA STAGE IV 36 0.1098
60 MYELOID LEUKAEMIA 54 0.1078
61 NEUTROPENIC SEPSIS 733 0.1025
62 VIRAEMIA 141 0.1017
63 PLASMA CELL LEUKAEMIA 61 0.1017
64 OTOTOXICITY 185 0.0999
65 STEM CELL TRANSPLANT 248 0.0992
66 KLEBSIELLA SEPSIS 111 0.0985
67 VIRAL HAEMORRHAGIC CYSTITIS 70 0.0983
68 COMPLICATIONS OF BONE MARROW TRANSPLANT 35 0.0970
69 KLEBSIELLA BACTERAEMIA 91 0.0958
70 HAEMATOTOXICITY 894 0.0940
71 AZOOSPERMIA 36 0.0938
72 PSEUDOMONAL BACTERAEMIA 80 0.0937
73 ACUTE MYELOID LEUKAEMIA 1451 0.0930
74 PLASMABLASTIC LYMPHOMA 33 0.0922
75 RADIATION OESOPHAGITIS 35 0.0919
76 FOLLICULAR LYMPHOMA 80 0.0909
77 DIFFUSE ALVEOLAR DAMAGE 104 0.0904
78 MUCOSAL INFLAMMATION 2346 0.0895
79 LYMPHOMA TRANSFORMATION 32 0.0889
80 ACUTE PROMYELOCYTIC LEUKAEMIA 91 0.0885
81 TUMOUR LYSIS SYNDROME 776 0.0881
82 SMALL CELL LUNG CANCER 133 0.0880
83 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 115 0.0873
84 FEBRILE BONE MARROW APLASIA 370 0.0870
85 MYELODYSPLASTIC SYNDROME 1203 0.0831
86 MINIMAL RESIDUAL DISEASE 40 0.0828
87 TRICHOSPORON INFECTION 33 0.0815
88 SUPERIOR VENA CAVA SYNDROME 49 0.0811
89 GRAFT VERSUS HOST DISEASE IN LIVER 58 0.0810
90 CYSTITIS VIRAL 31 0.0809
91 ENTEROCOCCAL BACTERAEMIA 85 0.0802
92 ENCEPHALITIS CYTOMEGALOVIRUS 35 0.0799
93 LOWER RESPIRATORY TRACT INFECTION FUNGAL 31 0.0797
94 CYTOPENIA 976 0.0796
95 FUSARIUM INFECTION 54 0.0771
96 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 576 0.0767
97 PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED 45 0.0759
98 GASTROINTESTINAL FUNGAL INFECTION 39 0.0757
99 ANGIOCENTRIC LYMPHOMA 37 0.0752
100 SKIN CANDIDA 39 0.0747
101 SECOND PRIMARY MALIGNANCY 620 0.0745
102 PLASMA CELL MYELOMA REFRACTORY 99 0.0740
103 CYTOGENETIC ABNORMALITY 83 0.0735
104 DIFFUSE LARGE B-CELL LYMPHOMA 560 0.0726
105 PULMONARY VASCULAR DISORDER 34 0.0722
106 HYPERFERRITINAEMIA 31 0.0719
107 SYSTEMIC MYCOSIS 84 0.0719
108 CYSTITIS HAEMORRHAGIC 287 0.0711
109 BRONCHOPULMONARY ASPERGILLOSIS 542 0.0698
110 HISTIOCYTOSIS HAEMATOPHAGIC 207 0.0697
111 CYTOMEGALOVIRUS VIRAEMIA 309 0.0694
112 PERIPHERAL MOTOR NEUROPATHY 97 0.0692
113 JC VIRUS INFECTION 109 0.0681
114 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 63 0.0681
115 HEPATITIS B REACTIVATION 215 0.0677
116 BK VIRUS INFECTION 228 0.0675
117 BONE MARROW TOXICITY 80 0.0675
118 PNEUMATOSIS INTESTINALIS 191 0.0669
119 BONE MARROW FAILURE 1345 0.0661
120 STREPTOCOCCAL BACTERAEMIA 71 0.0653
121 ACUTE MYELOID LEUKAEMIA RECURRENT 134 0.0624
122 ADENOVIRUS INFECTION 179 0.0617
123 NEOPLASM RECURRENCE 208 0.0613
124 ABDOMINAL COMPARTMENT SYNDROME 39 0.0612
125 FUNGAEMIA 96 0.0610
126 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 167 0.0604
127 ACUTE GRAFT VERSUS HOST DISEASE 274 0.0598
128 ESCHERICHIA BACTERAEMIA 140 0.0595
129 CENTRAL NERVOUS SYSTEM LYMPHOMA 81 0.0587
130 CLOSTRIDIUM DIFFICILE COLITIS 623 0.0587
131 MYELOSUPPRESSION 2115 0.0587
132 ASPERGILLOSIS 75 0.0574
133 CERVIX DISORDER 41 0.0569
134 LEUKAEMIA RECURRENT 95 0.0561
135 STENOTROPHOMONAS INFECTION 76 0.0560
136 ENTEROCOCCAL SEPSIS 45 0.0556
137 BACTERIAL SEPSIS 181 0.0555
138 FUNGAL SEPSIS 46 0.0554
139 THERAPY PARTIAL RESPONDER 861 0.0551
140 PNEUMONIA KLEBSIELLA 101 0.0549
141 CYTOMEGALOVIRUS INFECTION REACTIVATION 242 0.0547
142 CLOSTRIDIUM COLITIS 66 0.0544
143 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 39 0.0542
144 VENA CAVA THROMBOSIS 89 0.0535
145 PNEUMOCYSTIS JIROVECI PNEUMONIA 119 0.0534
146 ENTEROCOCCAL INFECTION 257 0.0531
147 GRAFT VERSUS HOST DISEASE IN SKIN 117 0.0531
148 SYSTEMIC CANDIDA 133 0.0529
149 KLEBSIELLA INFECTION 262 0.0518
150 PULMONARY VENO-OCCLUSIVE DISEASE 36 0.0514
151 STAPHYLOCOCCAL BACTERAEMIA 223 0.0513
152 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 108 0.0507
153 NEUROENDOCRINE CARCINOMA 35 0.0506
154 TRANSFORMATION TO ACUTE MYELOID LEUKAEMIA 33 0.0503
155 PANCYTOPENIA 2784 0.0498
156 ACUTE LYMPHOCYTIC LEUKAEMIA 141 0.0498
157 FANCONI SYNDROME 70 0.0495
158 CARDIOTOXICITY 439 0.0492
159 MUCORMYCOSIS 127 0.0488
160 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 41 0.0486
161 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 68 0.0481
162 GASTROINTESTINAL TOXICITY 231 0.0480
163 PREMATURE MENOPAUSE 44 0.0476
164 PULMONARY MYCOSIS 37 0.0475
165 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 452 0.0473
166 T-CELL LYMPHOMA 54 0.0471
167 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 83 0.0469
168 CANDIDA SEPSIS 42 0.0468
169 RHINOVIRUS INFECTION 182 0.0467
170 UTERINE ENLARGEMENT 36 0.0453
171 PERIPHERAL SENSORY NEUROPATHY 263 0.0449
172 BACTERAEMIA 533 0.0449
173 PERIPHERAL SENSORIMOTOR NEUROPATHY 56 0.0446
174 GASTROENTERITIS NOROVIRUS 59 0.0444
175 CHRONIC GRAFT VERSUS HOST DISEASE 160 0.0443
176 OESOPHAGEAL CANDIDIASIS 176 0.0441
177 AORTIC THROMBOSIS 51 0.0441
178 GENE MUTATION 87 0.0439
179 ESCHERICHIA SEPSIS 127 0.0438
180 HYPOGAMMAGLOBULINAEMIA 285 0.0433
181 EPSTEIN-BARR VIRAEMIA 48 0.0433
182 GRAFT VERSUS HOST DISEASE 311 0.0432
183 CEREBRAL TOXOPLASMOSIS 39 0.0418
184 TUMOUR NECROSIS 44 0.0416
185 RENAL TUBULAR DISORDER 116 0.0412
186 METASTASES TO ADRENALS 38 0.0412
187 PNEUMONIA CYTOMEGALOVIRAL 80 0.0412
188 EPSTEIN-BARR VIRUS INFECTION 256 0.0409
189 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 105 0.0407
190 STREPTOCOCCAL SEPSIS 48 0.0405
191 ENCEPHALITIS VIRAL 49 0.0402
192 ENTERITIS 255 0.0398
193 RADIATION PNEUMONITIS 85 0.0397
194 CAPILLARY LEAK SYNDROME 82 0.0396
195 VARICELLA ZOSTER VIRUS INFECTION 82 0.0395
196 PNEUMONIA FUNGAL 156 0.0395
197 PULMONARY TOXICITY 276 0.0390
198 HEPATOSPLENOMEGALY 99 0.0385
199 RECALL PHENOMENON 32 0.0383
200 DISEASE PROGRESSION 4531 0.0383
201 FEBRILE INFECTION 45 0.0382
202 NEPHROPATHY TOXIC 426 0.0379
203 BLOOD CULTURE POSITIVE 113 0.0377
204 NEUTROPENIA 5067 0.0372
205 THROMBOTIC MICROANGIOPATHY 363 0.0372
206 OESOPHAGEAL PERFORATION 31 0.0372
207 THROMBOCYTOPENIA 4139 0.0370
208 VENOUS THROMBOSIS 145 0.0369
209 CONTINUOUS HAEMODIAFILTRATION 36 0.0368
210 NEUROLOGICAL DECOMPENSATION 85 0.0367
211 GRANULOCYTE COUNT DECREASED 68 0.0366
212 SEPTIC SHOCK 1593 0.0366
213 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 186 0.0365
214 MANTLE CELL LYMPHOMA 55 0.0361
215 BACTERIAL INFECTION 669 0.0358
216 APLASTIC ANAEMIA 187 0.0358
217 LYMPHOPENIA 496 0.0350
218 PHARYNGEAL INFLAMMATION 42 0.0345
219 DRUG CLEARANCE DECREASED 45 0.0344
220 ACQUIRED GENE MUTATION 45 0.0343
221 MULTIPLE ORGAN DYSFUNCTION SYNDROME 972 0.0343
222 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 279 0.0338
223 BONE MARROW DISORDER 101 0.0334
224 METASTASES TO MENINGES 76 0.0334
225 MYELOPATHY 63 0.0331
226 CYTOMEGALOVIRUS INFECTION 547 0.0329
227 CYTOKINE RELEASE SYNDROME 658 0.0328
228 PLASMACYTOMA 61 0.0327
229 ENCEPHALITIS AUTOIMMUNE 43 0.0327
230 HYPOFIBRINOGENAEMIA 32 0.0323
231 BONE MARROW DEPRESSION 31 0.0318
232 HEPATITIS E 50 0.0316
233 CATHETER RELATED INFECTION 32 0.0316
234 BLOOD FIBRINOGEN DECREASED 36 0.0315
235 LEUKOENCEPHALOPATHY 116 0.0311
236 SKIN TOXICITY 174 0.0308
237 NEUTROPHIL COUNT ABNORMAL 87 0.0308
238 NEUROTOXICITY 537 0.0306
239 HYPOCHROMIC ANAEMIA 31 0.0306
240 ENTEROCOLITIS 176 0.0305
241 PULMONARY HAEMORRHAGE 238 0.0304
242 PNEUMONIA PSEUDOMONAL 46 0.0300
243 INFECTION REACTIVATION 34 0.0297
244 STRONGYLOIDIASIS 48 0.0297
245 STAPHYLOCOCCAL SEPSIS 145 0.0293
246 NEUTROPHIL COUNT DECREASED 1191 0.0292
247 DYSPLASIA 35 0.0292
248 PARAPARESIS 52 0.0292
249 BLOOD LACTATE DEHYDROGENASE INCREASED 461 0.0291
250 BICYTOPENIA 57 0.0291
251 NON-HODGKIN'S LYMPHOMA 38 0.0290
252 NEOPLASM PROGRESSION 971 0.0279
253 HEPATITIS B 168 0.0279
254 PSEUDOMONAS INFECTION 236 0.0275
255 PLASMA CELL MYELOMA RECURRENT 89 0.0274
256 B-CELL LYMPHOMA 93 0.0274
257 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 162 0.0273
258 METASTASIS 195 0.0273
259 PLATELET TRANSFUSION 35 0.0272
260 SUBILEUS 56 0.0269
261 SEPSIS 2998 0.0269
262 PNEUMOCYSTIS JIROVECII INFECTION 32 0.0268
263 ESCHERICHIA TEST POSITIVE 32 0.0267
264 HERPES SIMPLEX 172 0.0264
265 LEUKOPENIA 1300 0.0260
266 MENINGITIS BACTERIAL 37 0.0258
267 ACUTE RESPIRATORY DISTRESS SYNDROME 454 0.0256
268 CUTANEOUS T-CELL LYMPHOMA 32 0.0254
269 ENCEPHALOPATHY 618 0.0251
270 LUNG CONSOLIDATION 70 0.0250
271 PNEUMOCYSTIS JIROVECII PNEUMONIA 251 0.0250
272 CLOSTRIDIAL INFECTION 84 0.0248
273 QUADRIPARESIS 41 0.0247
274 DEAFNESS NEUROSENSORY 81 0.0246
275 HYPOALBUMINAEMIA 191 0.0245
276 DISSEMINATED INTRAVASCULAR COAGULATION 341 0.0242
277 METASTASES TO CENTRAL NERVOUS SYSTEM 311 0.0241
278 OESOPHAGITIS 256 0.0234
279 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 62 0.0233
280 TRAUMATIC LUNG INJURY 45 0.0233
281 PNEUMOMEDIASTINUM 42 0.0232
282 AGRANULOCYTOSIS 428 0.0230
283 NOROVIRUS INFECTION 33 0.0229
284 ENCEPHALITIS 158 0.0228
285 ARTERIAL THROMBOSIS 44 0.0227
286 CANDIDA INFECTION 384 0.0227
287 MYELITIS 35 0.0226
288 RECURRENT CANCER 92 0.0225
289 LEFT VENTRICULAR DYSFUNCTION 151 0.0225
290 JUGULAR VEIN THROMBOSIS 40 0.0225
291 PULMONARY ALVEOLAR HAEMORRHAGE 126 0.0224
292 DEVICE RELATED SEPSIS 45 0.0223
293 PNEUMONITIS 606 0.0222
294 IMMUNE-MEDIATED ENTEROCOLITIS 81 0.0220
295 METASTASES TO PERITONEUM 55 0.0218
296 MENINGITIS CRYPTOCOCCAL 38 0.0217
297 ACUTE LEUKAEMIA 35 0.0217
298 HYPOPHOSPHATAEMIA 158 0.0214
299 CYTOMEGALOVIRUS COLITIS 49 0.0213
300 AUTOIMMUNE HAEMOLYTIC ANAEMIA 73 0.0213
301 HYPERTRANSAMINASAEMIA 147 0.0211
302 SYSTEMIC INFECTION 35 0.0211
303 BONE MARROW TRANSPLANT 40 0.0211
304 LYMPHOMA 326 0.0211
305 SERUM FERRITIN INCREASED 111 0.0210
306 ESCHERICHIA INFECTION 173 0.0210
307 LUNG INFILTRATION 185 0.0209
308 GASTROINTESTINAL NECROSIS 61 0.0209
309 HYPOMAGNESAEMIA 291 0.0209
310 SOFT TISSUE INFECTION 38 0.0207
311 GASTRITIS HAEMORRHAGIC 31 0.0207
312 POLYNEUROPATHY 246 0.0205
313 FANCONI SYNDROME ACQUIRED 36 0.0205
314 METASTASES TO LYMPH NODES 138 0.0204
315 INFECTIOUS PLEURAL EFFUSION 31 0.0204
316 HYPERBILIRUBINAEMIA 208 0.0201
317 OSTEOLYSIS 41 0.0200
318 DRUG RESISTANCE 508 0.0198
319 OPTIC ATROPHY 32 0.0196
320 CYTOMEGALOVIRUS TEST POSITIVE 35 0.0196
321 HEPATOTOXICITY 433 0.0194
322 QUADRIPLEGIA 40 0.0194
323 MALIGNANT NEOPLASM PROGRESSION 1988 0.0194
324 INTRACARDIAC THROMBUS 59 0.0192
325 DIABETES INSIPIDUS 46 0.0191
326 METASTASES TO LUNG 220 0.0190
327 PAPILLARY THYROID CANCER 33 0.0190
328 LOBAR PNEUMONIA 35 0.0189
329 LYMPHADENOPATHY MEDIASTINAL 36 0.0188
330 TOXIC ENCEPHALOPATHY 95 0.0187
331 SMALL INTESTINAL PERFORATION 35 0.0186
332 STREPTOCOCCAL INFECTION 103 0.0185
333 GROWTH RETARDATION 54 0.0183
334 RESPIRATORY FAILURE 1314 0.0180
335 TUMOUR HAEMORRHAGE 51 0.0179
336 DRUG TOXICITY 242 0.0177
337 HYPERURICAEMIA 73 0.0177
338 DISEASE RECURRENCE 840 0.0176
339 MULTI-ORGAN FAILURE 305 0.0176
340 LUNG ABSCESS 37 0.0176
341 ANAEMIA 3353 0.0176
342 TRANSPLANT FAILURE 43 0.0175
343 HYPOPROTEINAEMIA 33 0.0174
344 CORONARY ARTERY THROMBOSIS 35 0.0173
345 HYPERPHOSPHATAEMIA 37 0.0172
346 ELECTROLYTE IMBALANCE 199 0.0171
347 CARDIOMYOPATHY 253 0.0171
348 CEREBRAL VENOUS THROMBOSIS 31 0.0171
349 COLITIS 646 0.0170
350 IMMUNE-MEDIATED LUNG DISEASE 31 0.0170
351 FUNGAL INFECTION 559 0.0168
352 IMMUNE-MEDIATED HEPATITIS 34 0.0166
353 HAEMODYNAMIC INSTABILITY 126 0.0165
354 EJECTION FRACTION DECREASED 257 0.0165
355 HYDROCEPHALUS 90 0.0165
356 EMBOLISM VENOUS 50 0.0165
357 ODYNOPHAGIA 97 0.0162
358 HYPOKALAEMIA 746 0.0161
359 FOETAL GROWTH RESTRICTION 98 0.0161
360 BRAIN HERNIATION 48 0.0161
361 GRANULOCYTOPENIA 91 0.0160
362 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 164 0.0160
363 HYPOPHYSITIS 32 0.0159
364 URINARY TRACT INFECTION BACTERIAL 40 0.0158
365 CANDIDIASIS 63 0.0157
366 LYMPHOPROLIFERATIVE DISORDER 46 0.0156
367 EMBOLISM 130 0.0156
368 GASTROINTESTINAL INFLAMMATION 122 0.0156
369 CARDIAC TAMPONADE 74 0.0156
370 MATERNAL EXPOSURE BEFORE PREGNANCY 106 0.0155
371 GUILLAIN-BARRE SYNDROME 75 0.0155
372 PLATELET DISORDER 39 0.0155
373 HYPERNATRAEMIA 77 0.0154
374 PLASMA CELL MYELOMA 601 0.0154
375 HYPERTRIGLYCERIDAEMIA 90 0.0154
376 DYSAESTHESIA 47 0.0153
377 ADRENAL INSUFFICIENCY 186 0.0153
378 ILEUS 190 0.0153
379 CLOSTRIDIUM TEST POSITIVE 33 0.0150
380 FIBROSIS 46 0.0149
381 VENTRICULAR HYPOKINESIA 48 0.0149
382 MULTIPLE-DRUG RESISTANCE 46 0.0148
383 COVID-19 PNEUMONIA 175 0.0148
384 THERAPY NON-RESPONDER 663 0.0147
385 VENTRICULAR DYSFUNCTION 38 0.0146
386 RETINAL HAEMORRHAGE 104 0.0146
387 WHITE BLOOD CELL DISORDER 39 0.0146
388 DEVICE RELATED INFECTION 224 0.0145
389 LYMPHADENOPATHY 513 0.0145
390 INFECTION 2053 0.0142
391 RESPIRATORY SYNCYTIAL VIRUS INFECTION 123 0.0141
392 VASCULAR DEVICE INFECTION 64 0.0141
393 NOCARDIOSIS 36 0.0141
394 PNEUMONIA BACTERIAL 129 0.0140
395 METASTASES TO LIVER 246 0.0140
396 HYPERPYREXIA 59 0.0139
397 STOMATITIS 844 0.0139
398 PNEUMONIA VIRAL 44 0.0138
399 CARDIAC DYSFUNCTION 51 0.0137
400 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 52 0.0136
401 HYPOVOLAEMIC SHOCK 65 0.0136
402 PNEUMOTHORAX 215 0.0135
403 SUBDURAL HAEMORRHAGE 37 0.0135
404 AREFLEXIA 36 0.0135
405 METASTATIC NEOPLASM 58 0.0134
406 THROMBOPHLEBITIS 47 0.0134
407 SPLENOMEGALY 157 0.0134
408 ACUTE HEPATIC FAILURE 183 0.0134
409 HYPOCALCAEMIA 253 0.0134
410 ATELECTASIS 129 0.0133
411 CHRONIC SINUSITIS 50 0.0133
412 AMYLASE INCREASED 49 0.0133
413 PLATELET COUNT DECREASED 1413 0.0132
414 ILEUS PARALYTIC 59 0.0132
415 MENINGITIS ASEPTIC 59 0.0131
416 VITREOUS HAEMORRHAGE 36 0.0130
417 CHRONIC MYELOID LEUKAEMIA 60 0.0130
418 LYMPHOCYTE COUNT DECREASED 229 0.0129
419 ORGANISING PNEUMONIA 64 0.0129
420 HAEMOGLOBIN ABNORMAL 83 0.0129
421 SUSPECTED OFF LABEL USE 58 0.0128
422 HEPATITIS FULMINANT 38 0.0128
423 IMMUNOSUPPRESSION 112 0.0127
424 DERMATOMYOSITIS 32 0.0126
425 RETINOPATHY 47 0.0126
426 STAPHYLOCOCCAL INFECTION 415 0.0126
427 NEOPLASM 144 0.0125
428 METASTASES TO SPINE 42 0.0125
429 HYPOTHYROIDISM 399 0.0125
430 HEPATIC LESION 54 0.0125
431 CONGESTIVE CARDIOMYOPATHY 52 0.0125
432 LUNG NEOPLASM 53 0.0124
433 EXTRAVASATION 51 0.0124
434 HYPOXIA 435 0.0123
435 BLOOD BILIRUBIN INCREASED 333 0.0123
436 ABDOMINAL MASS 33 0.0123
437 ACUTE RESPIRATORY FAILURE 236 0.0123
438 NEUROPATHY PERIPHERAL 1165 0.0122
439 HEPATIC NECROSIS 46 0.0122
440 PERICARDIAL EFFUSION 282 0.0122
441 RESPIRATORY DISTRESS 336 0.0122
442 CLOSTRIDIUM DIFFICILE INFECTION 265 0.0121
443 PARAPLEGIA 35 0.0121
444 INTESTINAL PERFORATION 136 0.0121
445 PLATELET COUNT ABNORMAL 73 0.0121
446 CARDIOPULMONARY FAILURE 47 0.0120
447 CACHEXIA 62 0.0120
448 PRODUCT USE IN UNAPPROVED INDICATION 2973 0.0120
449 PAPILLOEDEMA 54 0.0119
450 HYPERCAPNIA 36 0.0119
451 WHITE BLOOD CELL COUNT ABNORMAL 76 0.0119
452 HEPATIC FAILURE 359 0.0119
453 HYDRONEPHROSIS 89 0.0119
454 LEUKAEMIA 112 0.0119
455 VIRAL INFECTION 394 0.0118
456 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 649 0.0118
457 DERMATITIS EXFOLIATIVE GENERALISED 41 0.0118
458 HAEMODIALYSIS 99 0.0118
459 ASCITES 346 0.0118
460 LUNG OPACITY 31 0.0118
461 WHITE BLOOD CELL COUNT DECREASED 1255 0.0116
462 LARGE INTESTINE PERFORATION 80 0.0115
463 MONOPLEGIA 50 0.0115
464 BONE LESION 41 0.0114
465 IMMUNE THROMBOCYTOPENIA 52 0.0113
466 PLEURAL EFFUSION 687 0.0113
467 ABDOMINAL TENDERNESS 56 0.0113
468 ACUTE PULMONARY OEDEMA 63 0.0112
469 HEPATOMEGALY 110 0.0112
470 STRESS CARDIOMYOPATHY 65 0.0112
471 MALNUTRITION 125 0.0112
472 HERPES VIRUS INFECTION 64 0.0111
473 GASTROINTESTINAL PERFORATION 46 0.0111
474 MYOSITIS 99 0.0110
475 OLIGURIA 68 0.0109
476 SHOCK HAEMORRHAGIC 89 0.0109
477 METABOLIC DISORDER 63 0.0108
478 ESCHERICHIA URINARY TRACT INFECTION 46 0.0108
479 SMALL INTESTINAL OBSTRUCTION 133 0.0108
480 LIVER ABSCESS 35 0.0108
481 PERFORMANCE STATUS DECREASED 50 0.0107
482 TRANSAMINASES INCREASED 236 0.0106
483 HEPATIC CYST 36 0.0106
484 APPENDICITIS 99 0.0106
485 HYPONATRAEMIA 596 0.0106
486 BRAIN OEDEMA 133 0.0105
487 MYOCARDITIS 120 0.0105
488 HYPOVOLAEMIA 61 0.0104
489 NECROSIS 58 0.0104
490 HEPATIC FUNCTION ABNORMAL 387 0.0104
491 HYPERVOLAEMIA 51 0.0103
492 LUNG ADENOCARCINOMA 31 0.0103
493 TACHYPNOEA 140 0.0103
494 COAGULOPATHY 170 0.0102
495 HEARING IMPAIRED 61 0.0102
496 INTERSTITIAL LUNG DISEASE 488 0.0101
497 MYOPATHY 86 0.0099
498 METASTASES TO BONE 163 0.0099
499 NECROTISING FASCIITIS 35 0.0099
500 ALANINE AMINOTRANSFERASE INCREASED 609 0.0099
501 INFLAMMATORY MARKER INCREASED 49 0.0099
502 PYREXIA 3405 0.0098
503 PULMONARY FIBROSIS 188 0.0098
504 LUNG INFECTION 152 0.0098
505 CARDIAC FAILURE ACUTE 65 0.0097
506 RENAL TUBULAR NECROSIS 95 0.0097
507 DEAFNESS 253 0.0097
508 OFF LABEL USE 8393 0.0096
509 BLOOD ALBUMIN DECREASED 76 0.0096
510 HAEMORRHAGE INTRACRANIAL 140 0.0094
511 RENAL FAILURE ACUTE 395 0.0093
512 SUPRAVENTRICULAR TACHYCARDIA 89 0.0093
513 CEREBRAL ATROPHY 37 0.0093
514 CHRONIC LYMPHOCYTIC LEUKAEMIA 44 0.0093
515 URINE OUTPUT DECREASED 81 0.0093
516 SUBARACHNOID HAEMORRHAGE 94 0.0092
517 NON-SMALL CELL LUNG CANCER 44 0.0092
518 SINUS TACHYCARDIA 129 0.0091
519 VENTRICULAR ARRHYTHMIA 33 0.0090
520 PYELONEPHRITIS 78 0.0090
521 ORAL HERPES 175 0.0090
522 ABSCESS LIMB 38 0.0089
523 HEPATIC ENCEPHALOPATHY 83 0.0089
524 MOUTH ULCERATION 187 0.0089
525 ATAXIA 105 0.0088
526 MULTIPLE MYELOMA 41 0.0088
527 PARTIAL SEIZURES 46 0.0088
528 OPTIC ISCHAEMIC NEUROPATHY 34 0.0088
529 TRANSFUSION 92 0.0088
530 NERVOUS SYSTEM DISORDER 274 0.0088
531 ENDOCARDITIS 45 0.0088
532 ARTHRITIS BACTERIAL 36 0.0088
533 ACUTE KIDNEY INJURY 1330 0.0087
534 LIPASE INCREASED 66 0.0086
535 ORAL CANDIDIASIS 113 0.0086
536 C-REACTIVE PROTEIN INCREASED 311 0.0085
537 HEPATITIS CHOLESTATIC 51 0.0085
538 UROSEPSIS 78 0.0084
539 NO THERAPEUTIC RESPONSE 103 0.0084
540 CONJUNCTIVAL HAEMORRHAGE 32 0.0084
541 HEMIPARESIS 141 0.0083
542 FAILURE TO THRIVE 43 0.0083
543 INGUINAL HERNIA 50 0.0082
544 SARCOIDOSIS 39 0.0082
545 LOW BIRTH WEIGHT BABY 65 0.0082
546 ASPARTATE AMINOTRANSFERASE INCREASED 434 0.0082
547 RENAL IMPAIRMENT 677 0.0080
548 GENERALISED OEDEMA 99 0.0080
549 INTERVERTEBRAL DISC DISORDER 34 0.0080
550 RESPIRATORY TRACT INFECTION 207 0.0079
551 STATUS EPILEPTICUS 89 0.0079
552 ATRIAL FIBRILLATION 766 0.0079
553 ACIDOSIS 60 0.0078
554 MENINGITIS 52 0.0078
555 HYPERCALCAEMIA 96 0.0078
556 PNEUMONIA 2510 0.0077
557 CORONAVIRUS INFECTION 51 0.0077
558 SKIN NECROSIS 40 0.0077
559 CARDIAC FAILURE 614 0.0076
560 BLOOD DISORDER 61 0.0076
561 RENAL FAILURE 1008 0.0076
562 RASH MACULO-PAPULAR 167 0.0075
563 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 38 0.0075
564 INTESTINAL ISCHAEMIA 41 0.0074
565 DEEP VEIN THROMBOSIS 479 0.0074
566 ACUTE CORONARY SYNDROME 61 0.0074
567 PROTHROMBIN TIME PROLONGED 44 0.0073
568 CELLULITIS 369 0.0073
569 PROCTALGIA 47 0.0073
570 LEUKOCYTOSIS 132 0.0073
571 HAEMOPTYSIS 203 0.0073
572 HAEMOLYTIC ANAEMIA 65 0.0072
573 HYPERGLYCAEMIA 264 0.0072
574 ANURIA 62 0.0072
575 CEREBRAL INFARCTION 176 0.0072
576 TUBULOINTERSTITIAL NEPHRITIS 135 0.0072
577 NEUROLOGICAL SYMPTOM 41 0.0072
578 ATRIAL FLUTTER 57 0.0071
579 HYPERTHYROIDISM 102 0.0070
580 GAMMA-GLUTAMYLTRANSFERASE INCREASED 156 0.0070
581 MENTAL STATUS CHANGES 195 0.0070
582 CEREBRAL HAEMORRHAGE 250 0.0070
583 TOXIC SKIN ERUPTION 70 0.0069
584 TOXICITY TO VARIOUS AGENTS 1169 0.0069
585 RENAL CYST 55 0.0069
586 TONSILLITIS 36 0.0069
587 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 34 0.0068
588 PURPURA 60 0.0068
589 OSTEONECROSIS 222 0.0068
590 BLOOD CREATININE INCREASED 438 0.0067
591 HEPATOCELLULAR INJURY 95 0.0067
592 SHOCK 153 0.0066
593 TACHYCARDIA 582 0.0065
594 PULMONARY ARTERIAL HYPERTENSION 94 0.0065
595 TREATMENT FAILURE 536 0.0065
596 PROTEINURIA 123 0.0065
597 PULMONARY OEDEMA 289 0.0064
598 ANGIOPATHY 36 0.0064
599 PULMONARY EMBOLISM 610 0.0064
600 HEPATITIS 163 0.0064
601 PATHOGEN RESISTANCE 58 0.0064
602 HERPES ZOSTER 365 0.0063
603 HICCUPS 52 0.0063
604 BLOOD ALKALINE PHOSPHATASE INCREASED 157 0.0063
605 ACUTE MYOCARDIAL INFARCTION 186 0.0063
606 ASPIRATION 69 0.0063
607 PULMONARY HYPERTENSION 131 0.0063
608 INTRACRANIAL PRESSURE INCREASED 35 0.0063
609 HAEMOGLOBIN DECREASED 641 0.0062
610 CEREBRAL ISCHAEMIA 32 0.0062
611 SUBDURAL HAEMATOMA 88 0.0061
612 BLOOD UREA INCREASED 101 0.0060
613 HEMIPLEGIA 50 0.0060
614 CHOLECYSTITIS ACUTE 34 0.0060
615 NEPHROTIC SYNDROME 41 0.0060
616 TYPE 1 DIABETES MELLITUS 36 0.0060
617 CHOLANGITIS 37 0.0060
618 NEUTROPHIL COUNT INCREASED 61 0.0060
619 CHOLESTASIS 114 0.0059
620 CIRCULATORY COLLAPSE 101 0.0059
621 MITRAL VALVE INCOMPETENCE 67 0.0059
622 LUNG DISORDER 290 0.0059
623 LIVER DISORDER 261 0.0059
624 RESPIRATORY DISORDER 175 0.0058
625 HAEMATURIA 199 0.0058
626 ANAL ABSCESS 31 0.0057
627 MASS 80 0.0057
628 FLUID OVERLOAD 83 0.0057
629 HYPERVENTILATION 33 0.0057
630 SINUS BRADYCARDIA 55 0.0057
631 GENERAL PHYSICAL HEALTH DETERIORATION 656 0.0057
632 FACIAL PARALYSIS 48 0.0056
633 PLATELET COUNT INCREASED 73 0.0056
634 BLOOD MAGNESIUM DECREASED 48 0.0056
635 PETECHIAE 58 0.0056
636 HYPERTHERMIA 42 0.0055
637 HYPOTENSION 1100 0.0055
638 PERICARDITIS 92 0.0055
639 CENTRAL NERVOUS SYSTEM LESION 75 0.0055
640 INTENTIONAL PRODUCT USE ISSUE 478 0.0055
641 CHOLECYSTITIS 65 0.0055
642 TOXIC EPIDERMAL NECROLYSIS 82 0.0054
643 ABSCESS 86 0.0054
644 HEPATITIS ACUTE 35 0.0054
645 BLOOD URIC ACID INCREASED 31 0.0054
646 HAEMORRHAGE 561 0.0054
647 MYOCARDIAL ISCHAEMIA 61 0.0054
648 PULMONARY MASS 79 0.0053
649 LIVER INJURY 129 0.0053
650 SUDDEN DEATH 55 0.0052
651 GASTROINTESTINAL HAEMORRHAGE 433 0.0052
652 SPINAL PAIN 60 0.0051
653 INFUSION RELATED REACTION 339 0.0051
654 DRUG-INDUCED LIVER INJURY 160 0.0051
655 PRODUCT PRESCRIBING ISSUE 111 0.0051
656 CARDIOGENIC SHOCK 73 0.0051
657 PROCEDURAL COMPLICATION 39 0.0051
658 HYPOPHAGIA 130 0.0051
659 ORAL DISORDER 37 0.0050
660 CYANOSIS 79 0.0050
661 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 113 0.0048
662 SKIN INFECTION 54 0.0048
663 GASTROINTESTINAL INFECTION 43 0.0048
664 HAEMATOCRIT DECREASED 95 0.0048
665 TRICUSPID VALVE INCOMPETENCE 38 0.0048
666 DRUG ERUPTION 84 0.0047
667 PULMONARY CONGESTION 62 0.0047
668 DERMATITIS BULLOUS 34 0.0047
669 UPPER GASTROINTESTINAL HAEMORRHAGE 79 0.0047
670 DYSPHAGIA 439 0.0046
671 GASTROENTERITIS 67 0.0046
672 ALTERED STATE OF CONSCIOUSNESS 99 0.0046
673 VOMITING 2144 0.0046
674 JAUNDICE 122 0.0045
675 DEHYDRATION 604 0.0045
676 APHASIA 136 0.0045
677 VENTRICULAR FIBRILLATION 50 0.0045
678 MOUTH HAEMORRHAGE 33 0.0045
679 PANCREATITIS ACUTE 101 0.0045
680 ANOREXIA 57 0.0044
681 OXYGEN SATURATION DECREASED 248 0.0044
682 BODY TEMPERATURE INCREASED 90 0.0044
683 PREMATURE DELIVERY 70 0.0044
684 RESPIRATORY RATE INCREASED 39 0.0044
685 NEPHROPATHY 41 0.0044
686 ISCHAEMIC STROKE 78 0.0044
687 CARDIAC ARREST 360 0.0044
688 GRAND MAL CONVULSION 40 0.0043
689 ORAL PAIN 96 0.0043
690 PREMATURE BABY 129 0.0043
691 METABOLIC ACIDOSIS 136 0.0042
692 DERMATITIS 89 0.0042
693 ANAPHYLACTIC REACTION 234 0.0042
694 GENERALISED TONIC-CLONIC SEIZURE 70 0.0042
695 BRONCHOSPASM 60 0.0042
696 BASAL CELL CARCINOMA 65 0.0042
697 CARDIOMEGALY 51 0.0041
698 CYSTITIS 132 0.0041
699 EYELID PTOSIS 42 0.0041
700 THERAPEUTIC RESPONSE DECREASED 249 0.0041
701 IMMUNODEFICIENCY 61 0.0041
702 HAEMATEMESIS 103 0.0041
703 INFLAMMATION 209 0.0040
704 SKIN LESION 111 0.0040
705 BLOOD SODIUM DECREASED 76 0.0040
706 DIARRHOEA HAEMORRHAGIC 37 0.0040
707 MELAENA 87 0.0039
708 HYPERKALAEMIA 138 0.0039
709 TENDERNESS 41 0.0039
710 MOTOR DYSFUNCTION 40 0.0039
711 BONE PAIN 229 0.0039
712 PHARYNGITIS 48 0.0039
713 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 275 0.0039
714 HEPATIC STEATOSIS 72 0.0039
715 PRODUCT USE ISSUE 724 0.0038
716 ORTHOSTATIC HYPOTENSION 67 0.0038
717 DISORIENTATION 152 0.0038
718 AMENORRHOEA 67 0.0038
719 CONVULSION 218 0.0038
720 HYPOTONIA 38 0.0038
721 WHITE BLOOD CELL COUNT INCREASED 146 0.0038
722 EPISTAXIS 283 0.0038
723 PERITONITIS 78 0.0038
724 OEDEMA 204 0.0038
725 DECREASED APPETITE 867 0.0037
726 BRADYCARDIA 197 0.0037
727 SEIZURE 428 0.0037
728 ABDOMINAL PAIN 859 0.0037
729 PNEUMONIA ASPIRATION 92 0.0037
730 DEPRESSED LEVEL OF CONSCIOUSNESS 145 0.0037
731 THYROID CANCER 44 0.0037
732 HAEMATOMA 94 0.0036
733 NEURALGIA 88 0.0036
734 DRUG INEFFECTIVE 4758 0.0036
735 COMA 171 0.0036
736 CARDIO-RESPIRATORY ARREST 150 0.0036
737 PRODUCTIVE COUGH 171 0.0036
738 EMPHYSEMA 36 0.0036
739 SENSORY DISTURBANCE 57 0.0035
740 DIARRHOEA 2279 0.0035
741 DRUG INTOLERANCE 341 0.0035
742 RED BLOOD CELL SEDIMENTATION RATE INCREASED 39 0.0035
743 RESPIRATORY DEPRESSION 43 0.0035
744 EPILEPSY 107 0.0035
745 IMMUNE SYSTEM DISORDER 46 0.0035
746 NIGHT SWEATS 112 0.0035
747 FULL BLOOD COUNT DECREASED 70 0.0035
748 HEPATIC CYTOLYSIS 44 0.0034
749 OROPHARYNGEAL DISCOMFORT 31 0.0034
750 RED BLOOD CELL COUNT DECREASED 98 0.0034
751 UNRESPONSIVE TO STIMULI 88 0.0034
752 INCONTINENCE 36 0.0034
753 DELIRIUM 118 0.0034
754 GASTROINTESTINAL DISORDER 303 0.0034
755 BLOOD CALCIUM DECREASED 38 0.0034
756 DIPLOPIA 87 0.0033
757 ERYTHEMA MULTIFORME 31 0.0033
758 CHILLS 389 0.0033
759 HYPOKINESIA 48 0.0033
760 GASTRIC HAEMORRHAGE 38 0.0033
761 CONSTIPATION 720 0.0033
762 DEATH 2838 0.0033
763 ARRHYTHMIA 156 0.0033
764 COVID-19 576 0.0033
765 CONDITION AGGRAVATED 992 0.0033
766 VASCULITIS 38 0.0033
767 CONFUSIONAL STATE 521 0.0032
768 ANAPHYLACTIC SHOCK 83 0.0032
769 BLINDNESS 131 0.0032
770 INTESTINAL OBSTRUCTION 121 0.0032
771 SYNCOPE 320 0.0032
772 DRUG INTERACTION 505 0.0032
773 VENTRICULAR EXTRASYSTOLES 33 0.0032
774 NAUSEA 2495 0.0031
775 URINARY RETENTION 105 0.0031
776 DYSPNOEA EXERTIONAL 118 0.0031
777 TINNITUS 143 0.0031
778 LIVER FUNCTION TEST ABNORMAL 90 0.0031
779 MUSCULAR WEAKNESS 351 0.0031
780 HYPOTHERMIA 31 0.0031
781 BLOOD POTASSIUM DECREASED 92 0.0031
782 OBSTRUCTIVE AIRWAYS DISORDER 34 0.0031
783 ASTHENIA 1142 0.0030
784 DIALYSIS 43 0.0030
785 UPPER RESPIRATORY TRACT INFECTION 140 0.0030
786 ILL-DEFINED DISORDER 181 0.0030
787 PANCREATITIS 155 0.0029
788 COGNITIVE DISORDER 133 0.0028
789 VENTRICULAR TACHYCARDIA 47 0.0028
790 FLUSHING 289 0.0028
791 DRUG LEVEL INCREASED 47 0.0028
792 HYPERTENSION 601 0.0028
793 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 82 0.0028
794 DRUG EFFECT INCOMPLETE 100 0.0028
795 DYSPNOEA 1554 0.0027
796 LOWER RESPIRATORY TRACT INFECTION 123 0.0027
797 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 46 0.0027
798 PARALYSIS 38 0.0027
799 OBESITY 42 0.0026
800 OSTEOMYELITIS 47 0.0026
801 GASTRITIS 68 0.0026
802 OEDEMA PERIPHERAL 313 0.0026
803 RENAL DISORDER 119 0.0026
804 SKIN ULCER 66 0.0026
805 COUGH 712 0.0025
806 MUSCLE SPASTICITY 31 0.0025
807 HEPATIC ENZYME INCREASED 170 0.0025
808 MATERNAL EXPOSURE DURING PREGNANCY 222 0.0025
809 URINARY TRACT INFECTION 423 0.0025
810 PSYCHOTIC DISORDER 73 0.0025
811 DYSARTHRIA 93 0.0025
812 DIVERTICULITIS 68 0.0025
813 NEOPLASM MALIGNANT 163 0.0024
814 THROMBOSIS 195 0.0024
815 RECTAL HAEMORRHAGE 104 0.0024
816 FEEDING DISORDER 49 0.0024
817 PALLOR 65 0.0024
818 PRESYNCOPE 57 0.0023
819 FOETAL EXPOSURE DURING PREGNANCY 189 0.0023
820 HYPOACUSIS 100 0.0023
821 HAEMORRHOIDS 45 0.0023
822 COORDINATION ABNORMAL 32 0.0023
823 SKIN DISORDER 76 0.0023
824 ALOPECIA 446 0.0023
825 ABDOMINAL PAIN LOWER 57 0.0023
826 STEVENS-JOHNSON SYNDROME 50 0.0022
827 LETHARGY 128 0.0022
828 CHEST DISCOMFORT 227 0.0022
829 RESPIRATORY ARREST 61 0.0022
830 MUSCULOSKELETAL CHEST PAIN 34 0.0022
831 FACE OEDEMA 37 0.0022
832 GASTRIC ULCER 41 0.0022
833 RASH ERYTHEMATOUS 103 0.0022
834 DYSURIA 79 0.0021
835 RHABDOMYOLYSIS 89 0.0021
836 CHEST PAIN 395 0.0021
837 LIVER FUNCTION TEST INCREASED 45 0.0021
838 OROPHARYNGEAL PAIN 194 0.0021
839 BLOOD POTASSIUM INCREASED 34 0.0021
840 URINARY INCONTINENCE 62 0.0021
841 INTERNATIONAL NORMALISED RATIO INCREASED 59 0.0021
842 CARDIAC FAILURE CONGESTIVE 166 0.0021
843 BLOOD TRIGLYCERIDES INCREASED 36 0.0020
844 EATING DISORDER 43 0.0020
845 ERYTHEMA 411 0.0020
846 CONJUNCTIVITIS 37 0.0020
847 PELVIC PAIN 36 0.0020
848 ELECTROCARDIOGRAM QT PROLONGED 71 0.0020
849 SLEEP APNOEA SYNDROME 37 0.0019
850 WEIGHT DECREASED 540 0.0019
851 BLOOD PRESSURE DECREASED 128 0.0019
852 FATIGUE 1497 0.0019
853 DIABETIC KETOACIDOSIS 46 0.0019
854 ANGINA PECTORIS 54 0.0019
855 LUNG NEOPLASM MALIGNANT 77 0.0019
856 BACK PAIN 434 0.0019
857 POST PROCEDURAL COMPLICATION 35 0.0018
858 MUSCULOSKELETAL PAIN 95 0.0018
859 CARDIOVASCULAR DISORDER 46 0.0018
860 LACTIC ACIDOSIS 58 0.0018
861 SPEECH DISORDER 93 0.0018
862 SINUSITIS 181 0.0018
863 BLOOD CREATINE PHOSPHOKINASE INCREASED 50 0.0017
864 HYPOAESTHESIA 257 0.0017
865 ABDOMINAL DISTENSION 179 0.0017
866 TOOTH DISORDER 38 0.0017
867 PARAESTHESIA 268 0.0017
868 BONE DISORDER 31 0.0017
869 LOSS OF CONSCIOUSNESS 217 0.0017
870 EXPOSURE DURING PREGNANCY 105 0.0017
871 LABORATORY TEST ABNORMAL 49 0.0017
872 RENAL INJURY 49 0.0016
873 HYPOGLYCAEMIA 79 0.0016
874 RHINORRHOEA 105 0.0016
875 EAR PAIN 31 0.0016
876 RASH 693 0.0016
877 PAIN IN JAW 44 0.0016
878 AGITATION 114 0.0016
879 TRANSIENT ISCHAEMIC ATTACK 52 0.0015
880 INFLUENZA 170 0.0015
881 CHRONIC KIDNEY DISEASE 113 0.0015
882 THROAT TIGHTNESS 40 0.0015
883 CARDIAC DISORDER 138 0.0015
884 GASTRIC CANCER 37 0.0015
885 DISTURBANCE IN ATTENTION 78 0.0014
886 RESTLESSNESS 51 0.0014
887 LIP SWELLING 46 0.0014
888 HYPERSENSITIVITY 255 0.0014
889 CHOLELITHIASIS 45 0.0014
890 DYSPHONIA 76 0.0013
891 HEART RATE INCREASED 126 0.0013
892 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 66 0.0013
893 CONTRAINDICATED PRODUCT ADMINISTERED 38 0.0013
894 VAGINAL HAEMORRHAGE 54 0.0012
895 MYALGIA 210 0.0012
896 HAEMATOCHEZIA 68 0.0012
897 PAIN IN EXTREMITY 363 0.0012
898 HYPERHIDROSIS 157 0.0012
899 HEADACHE 762 0.0012
900 MYOCARDIAL INFARCTION 212 0.0012
901 DYSGEUSIA 90 0.0012
902 DYSPEPSIA 119 0.0012
903 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 31 0.0012
904 VISUAL ACUITY REDUCED 40 0.0012
905 RASH PRURITIC 64 0.0012
906 SOMNOLENCE 237 0.0012
907 TYPE 2 DIABETES MELLITUS 39 0.0012
908 MOBILITY DECREASED 82 0.0011
909 WHEEZING 67 0.0011
910 NECK PAIN 63 0.0011
911 CEREBROVASCULAR ACCIDENT 190 0.0011
912 BRONCHITIS 82 0.0011
913 ADVERSE EVENT 102 0.0011
914 DIZZINESS 552 0.0011
915 BLISTER 62 0.0011
916 SWELLING FACE 71 0.0011
917 MOVEMENT DISORDER 35 0.0011
918 CATARACT 64 0.0011
919 FEMUR FRACTURE 33 0.0011
920 POLLAKIURIA 44 0.0011
921 BALANCE DISORDER 91 0.0011
922 ABDOMINAL PAIN UPPER 216 0.0010
923 HALLUCINATION 79 0.0010
924 OSTEOPOROSIS 42 0.0010
925 ANGIOEDEMA 45 0.0010
926 TREMOR 168 0.0010
927 THERAPEUTIC PRODUCT EFFECT DECREASED 45 0.0010
928 GAIT DISTURBANCE 192 0.0010
929 NO ADVERSE EVENT 178 0.0010
930 IMPAIRED HEALING 32 0.0010
931 PAIN 590 0.0010
932 VERTIGO 57 0.0009
933 DIABETES MELLITUS 71 0.0009
934 VISUAL IMPAIRMENT 115 0.0009
935 FLUID RETENTION 47 0.0009
936 TREATMENT NONCOMPLIANCE 50 0.0009
937 SKIN EXFOLIATION 77 0.0009
938 UNEVALUABLE EVENT 66 0.0009
939 FALL 289 0.0009
940 MALAISE 375 0.0009
941 MENTAL DISORDER 37 0.0008
942 SWELLING 77 0.0008
943 PALPITATIONS 96 0.0008
944 ARTHRALGIA 340 0.0008
945 FEELING HOT 50 0.0008
946 DEPRESSION 185 0.0008
947 PRURITUS 303 0.0008
948 DYSKINESIA 32 0.0008
949 MEDICATION ERROR 41 0.0007
950 SKIN DISCOLOURATION 33 0.0007
951 BLOOD PRESSURE INCREASED 109 0.0007
952 WEIGHT INCREASED 159 0.0007
953 SLEEP DISORDER 50 0.0007
954 OCULAR HYPERAEMIA 32 0.0007
955 IRRITABILITY 40 0.0007
956 DISCOMFORT 40 0.0007
957 VISION BLURRED 89 0.0006
958 DRY MOUTH 52 0.0006
959 GASTROOESOPHAGEAL REFLUX DISEASE 50 0.0006
960 MEMORY IMPAIRMENT 83 0.0006
961 PROSTATE CANCER 48 0.0006
962 MUSCLE SPASMS 109 0.0006
963 ABDOMINAL DISCOMFORT 96 0.0006
964 AMNESIA 37 0.0006
965 EYE PAIN 31 0.0005
966 CONTUSION 50 0.0005
967 DEVICE MALFUNCTION 36 0.0005
968 INJECTION SITE REACTION 35 0.0005
969 ARTHRITIS 40 0.0005
970 ANXIETY 139 0.0005
971 HOSPITALISATION 73 0.0005
972 URTICARIA 79 0.0005
973 INSOMNIA 123 0.0005
974 ADVERSE DRUG REACTION 41 0.0005
975 DRUG ABUSE 38 0.0005
976 PERIPHERAL SWELLING 70 0.0005
977 BLOOD GLUCOSE INCREASED 84 0.0004
978 HOT FLUSH 33 0.0004
979 DRY SKIN 55 0.0004
980 BREAST CANCER 35 0.0004
981 EMOTIONAL DISTRESS 41 0.0003
982 MIGRAINE 32 0.0003
983 OVERDOSE 69 0.0003
984 FEELING ABNORMAL 72 0.0003
985 PSORIASIS 36 0.0003
986 NASOPHARYNGITIS 50 0.0003
987 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 31 0.0002